# Bacteriophage Therapy for Methicillin-Sensitive Staphylococcus Aureus Prosthetic Joint Infection

> **NCT06456424** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **University of Calgary** · enrollment: 1 (actual)

## Conditions studied

- Prosthetic Joint Infections of Hip
- Staphylococcus Aureus Infection

## Interventions

- **BIOLOGICAL:** Phage therapy

## Key facts

- **NCT ID:** NCT06456424
- **Lead sponsor:** University of Calgary
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-11-20
- **Primary completion:** 2025-11
- **Final completion:** 2025-11
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2025-06-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06456424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06456424, "Bacteriophage Therapy for Methicillin-Sensitive Staphylococcus Aureus Prosthetic Joint Infection". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06456424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*